$AMED
AMEDISYS INC

2018 Q4 Form 10-Q Financial Statement

#000089626218000010 Filed on October 30, 2018

View on sec.gov

Income Statement

Concept 2018 Q4 2018 Q3 2017 Q3
Revenue $434.4M $417.3M $373.7M
YoY Change 9.15% 11.67% 3.35%
Cost Of Revenue $262.3M $249.7M $227.3M
YoY Change 9.66% 9.87% 7.15%
Gross Profit $172.1M $167.6M $146.4M
YoY Change 8.44% 14.48% -2.07%
Gross Profit Margin 39.62% 40.16% 39.18%
Selling, General & Admin $132.3M $124.5M $118.9M
YoY Change 6.95% 4.71% -8.47%
% of Gross Profit 76.87% 74.28% 81.22%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.400M $3.200M $4.100M
YoY Change -15.0% -21.95% -22.64%
% of Gross Profit 1.98% 1.91% 2.8%
Operating Expenses $135.7M $127.7M $123.0M
YoY Change 6.26% 3.82% -8.96%
Operating Profit $36.40M $39.90M $23.37M
YoY Change 17.42% 70.71% 62.78%
Interest Expense -$300.0K $1.991M $1.335M
YoY Change -72.73% 49.14% -36.43%
% of Operating Profit -0.82% 4.99% 5.71%
Other Income/Expense, Net $1.500M $1.485M $652.0K
YoY Change -40.0% 127.76% -83.0%
Pretax Income $36.60M $41.37M $24.03M
YoY Change 25.77% 72.21% 32.05%
Income Tax $8.900M $9.825M $9.364M
% Of Pretax Income 24.32% 23.75% 38.98%
Net Earnings $27.50M $31.40M $14.60M
YoY Change -823.68% 115.07% 28.07%
Net Earnings / Revenue 6.33% 7.52% 3.91%
Basic Earnings Per Share $0.86 $0.99 $0.43
Diluted Earnings Per Share $0.84 $0.96 $0.42
COMMON SHARES
Basic Shares Outstanding 31.89M shares 31.82M shares 33.84M shares
Diluted Shares Outstanding 32.69M shares 34.36M shares

Balance Sheet

Concept 2018 Q4 2018 Q3 2017 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $20.20M $14.00M $66.10M
YoY Change -76.62% -78.82% 642.7%
Cash & Equivalents $20.20M $14.01M $66.11M
Short-Term Investments
Other Short-Term Assets $7.300M $11.95M $24.70M
YoY Change -55.13% -51.62% 12.27%
Inventory
Prepaid Expenses $7.568M $11.68M
Receivables $189.0M $195.0M $177.4M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $224.1M $232.7M $268.2M
YoY Change -27.97% -13.25% 38.68%
LONG-TERM ASSETS
Property, Plant & Equipment $29.40M $30.22M $32.70M
YoY Change -5.47% -7.6% -23.95%
Goodwill $329.5M $324.1M
YoY Change 3.0%
Intangibles $44.10M $44.31M
YoY Change -4.34%
Long-Term Investments
YoY Change
Other Assets $54.10M $53.41M $140.1M
YoY Change 10.18% -61.88% -8.73%
Total Long-Term Assets $493.0M $493.2M $531.3M
YoY Change -1.86% -7.17% 0.57%
TOTAL ASSETS
Total Short-Term Assets $224.1M $232.7M $268.2M
Total Long-Term Assets $493.0M $493.2M $531.3M
Total Assets $717.1M $725.9M $799.5M
YoY Change -11.85% -9.21% 10.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $28.53M $24.52M $22.82M
YoY Change 12.4% 7.47% -31.07%
Accrued Expenses $99.50M $101.2M $83.52M
YoY Change 11.67% 21.15% -41.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.600M $1.200M $9.400M
YoY Change -84.91% -87.23% 80.77%
Total Short-Term Liabilities $222.5M $219.3M $201.9M
YoY Change 3.45% 8.61% 10.81%
LONG-TERM LIABILITIES
Long-Term Debt $5.800M $54.90M $80.50M
YoY Change -92.58% -31.8% -9.45%
Other Long-Term Liabilities $6.200M $6.253M $3.900M
YoY Change 63.55% 60.33% -9.3%
Total Long-Term Liabilities $12.00M $61.15M $80.50M
YoY Change -85.36% -24.03% -9.45%
TOTAL LIABILITIES
Total Short-Term Liabilities $222.5M $219.3M $201.9M
Total Long-Term Liabilities $12.00M $61.15M $80.50M
Total Liabilities $234.5M $280.4M $286.3M
YoY Change -21.06% -2.07% 3.62%
SHAREHOLDERS EQUITY
Retained Earnings $119.6M $92.09M
YoY Change 58502.94%
Common Stock $603.7M $592.5M $561.4M
YoY Change 6.13% 5.55%
Preferred Stock
YoY Change
Treasury Stock (at cost) $241.7M $240.5M $53.23M
YoY Change 349.96% 351.9%
Treasury Stock Shares 4.279M shares 4.269M shares
Shareholders Equity $481.6M $444.1M $512.3M
YoY Change
Total Liabilities & Shareholders Equity $717.1M $725.9M $799.5M
YoY Change -11.85% -9.21% 10.78%

Cashflow Statement

Concept 2018 Q4 2018 Q3 2017 Q3
OPERATING ACTIVITIES
Net Income $27.50M $31.40M $14.60M
YoY Change -823.68% 115.07% 28.07%
Depreciation, Depletion And Amortization $3.400M $3.200M $4.100M
YoY Change -15.0% -21.95% -22.64%
Cash From Operating Activities $64.00M $68.50M $10.20M
YoY Change 98.76% 571.57% 50.0%
INVESTING ACTIVITIES
Capital Expenditures -$900.0K -$4.100M -$1.700M
YoY Change -43.75% 141.18% -52.78%
Acquisitions
YoY Change
Other Investing Activities -$8.700M -$3.300M $200.0K
YoY Change -8.42% -1750.0% -104.88%
Cash From Investing Activities -$9.600M -$7.400M -$1.500M
YoY Change -13.51% 393.33% -80.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -48.20M -73.00M -1.800M
YoY Change 5925.0% 3955.56% 800.0%
NET CHANGE
Cash From Operating Activities 64.00M 68.50M 10.20M
Cash From Investing Activities -9.600M -7.400M -1.500M
Cash From Financing Activities -48.20M -73.00M -1.800M
Net Change In Cash 6.200M -11.90M 6.900M
YoY Change -69.46% -272.46% -790.0%
FREE CASH FLOW
Cash From Operating Activities $64.00M $68.50M $10.20M
Capital Expenditures -$900.0K -$4.100M -$1.700M
Free Cash Flow $64.90M $72.60M $11.90M
YoY Change 92.01% 510.08% 14.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q4 amed Accounts Receivable Portion Derived From Medicare
AccountsReceivablePortionDerivedFromMedicare
0.59
CY2018Q3 amed Accounts Receivable Portion Derived From Medicare
AccountsReceivablePortionDerivedFromMedicare
0.55
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
216000 USD
amed Cash Distribution To Noncontrolling Interest
CashDistributionToNoncontrollingInterest
530000 USD
CY2018Q3 amed Consolidated Interest Coverage Ratio
ConsolidatedInterestCoverageRatio
57.6
CY2014Q2 amed Corporate Integrity Agreement Term
CorporateIntegrityAgreementTerm
P5Y
CY2018Q3 amed Debt Instrument Carrying Amount Excluding Capital Leases
DebtInstrumentCarryingAmountExcludingCapitalLeases
58100000 USD
amed Episode Of Care As Episodic Based Revenue Duration
EpisodeOfCareAsEpisodicBasedRevenueDuration
P60D
amed First Threshold Of Therapy Services Required
FirstThresholdOfTherapyServicesRequired
6 visit
amed Health Insurance Retention Limit
HealthInsuranceRetentionLimit
1000000 USD
amed Historical Collection Rate From Medicare
HistoricalCollectionRateFromMedicare
0.99
CY2017Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.97
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.97
CY2018Q3 amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.98
amed Hospice Medicare Revenue Rate Accounted For Routine Care
HospiceMedicareRevenueRateAccountedForRoutineCare
0.97
amed Low Utilization Payment Adjustment Number Of Visits
LowUtilizationPaymentAdjustmentNumberOfVisits
5 visit
amed Maximum Days To Submit Final Bill From Date Request For Anticipated Payment Was Paid
MaximumDaysToSubmitFinalBillFromDateRequestForAnticipatedPaymentWasPaid
60 day
amed Maximum Days To Submit Final Bill From Start Of Episode
MaximumDaysToSubmitFinalBillFromStartOfEpisode
120 day
CY2018Q3 amed Maximum Percent Ownership For Cost Method Percent
MaximumPercentOwnershipForCostMethodPercent
0.20
CY2018Q3 amed Maximum Percent Ownership For Equity Method Percent
MaximumPercentOwnershipForEquityMethodPercent
0.5
CY2018Q3 amed Minimum Percent Ownership For Controlling Interest Percent
MinimumPercentOwnershipForControllingInterestPercent
0.5
amed Net Service Revenue Episode Payment Rate Duration
NetServiceRevenueEpisodePaymentRateDuration
P60D
CY2017Q3 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
254000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
336000 shares
CY2018Q3 amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
315000 shares
amed Non Vested Stock And Stock Units
NonVestedStockAndStockUnits
313000 shares
amed Payments For Repurchase Of Noncontrolling Interest
PaymentsForRepurchaseOfNoncontrollingInterest
0 USD
amed Payments For Repurchase Of Noncontrolling Interest
PaymentsForRepurchaseOfNoncontrollingInterest
361000 USD
amed Percentage Of Patient Receivables Outstanding
PercentageOfPatientReceivablesOutstanding
0.1
amed Percentage Of Total Reimbursement Of Outlier Payment
PercentageOfTotalReimbursementOfOutlierPayment
0.1
amed Professional Liability Insurance Retention Limit
ProfessionalLiabilityInsuranceRetentionLimit
300000 USD
amed Rate Of Request For Anticipated Payment Submitted For Initial Episode Of Care
RateOfRequestForAnticipatedPaymentSubmittedForInitialEpisodeOfCare
0.60
amed Rate Of Request For Anticipated Payment Submitted For Subsequent Episodes Of Care
RateOfRequestForAnticipatedPaymentSubmittedForSubsequentEpisodesOfCare
0.50
amed Second Threshold Of Services Required
SecondThresholdOfServicesRequired
14 visit
CY2017Q3 amed Securities Class Action Lawsuitsettlement
SecuritiesClassActionLawsuitsettlement
0 USD
amed Securities Class Action Lawsuitsettlement
SecuritiesClassActionLawsuitsettlement
28712000 USD
amed Securities Class Action Lawsuitsettlement
SecuritiesClassActionLawsuitsettlement
28700000 USD
CY2018Q3 amed Securities Class Action Lawsuitsettlement
SecuritiesClassActionLawsuitsettlement
0 USD
amed Securities Class Action Lawsuitsettlement
SecuritiesClassActionLawsuitsettlement
0 USD
amed Third Threshold Of Therapy Services Required
ThirdThresholdOfTherapyServicesRequired
20 visit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2018
dei Document Period End Date
DocumentPeriodEndDate
2018-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0000896262
CY2018Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31888599 shares
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
AMEDISYS INC
dei Trading Symbol
TradingSymbol
AMED
CY2018Q3 amed Total Leverage Ratio
TotalLeverageRatio
0.4
amed Workers Compensation Insurance Retention Limit
WorkersCompensationInsuranceRetentionLimit
500000 USD
dei Amendment Flag
AmendmentFlag
false
CY2017Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
25384000 USD
CY2018Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
24519000 USD
CY2017Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
201196000 USD
CY2018Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
195030000 USD
CY2017Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
89104000 USD
CY2018Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
101177000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
146814000 USD
CY2017Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
146800000 USD
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
93400000 USD
CY2018Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
93432000 USD
CY2017Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000 USD
CY2018Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
15000 USD
CY2017Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
568780000 USD
CY2018Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
592539000 USD
CY2017Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
555000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
596000 USD
CY2017Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
337000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
279000 shares
CY2018Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
51000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
76000 shares
CY2017Q4 us-gaap Assets
Assets
813482000 USD
CY2018Q3 us-gaap Assets
Assets
725892000 USD
CY2017Q4 us-gaap Assets Current
AssetsCurrent
311156000 USD
CY2018Q3 us-gaap Assets Current
AssetsCurrent
232668000 USD
CY2016Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
30197000 USD
CY2017Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66114000 USD
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
86363000 USD
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14010000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
35917000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-72353000 USD
CY2018Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2017Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2018Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2017Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
35747134 shares
CY2018Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
36146649 shares
CY2018Q3 us-gaap Cost Of Services
CostOfServices
249700000 USD
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
350331000 USD
CY2017Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
33964767 shares
CY2018Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31877278 shares
CY2017Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
35000 USD
CY2018Q3 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
36000 USD
CY2017Q3 us-gaap Cost Of Services
CostOfServices
227300000 USD
CY2017Q3 us-gaap Cost Of Services
CostOfServices
227269000 USD
us-gaap Cost Of Services
CostOfServices
664139000 USD
us-gaap Cost Of Services
CostOfServices
664100000 USD
CY2018Q3 us-gaap Cost Of Services
CostOfServices
249739000 USD
us-gaap Cost Of Services
CostOfServices
730600000 USD
us-gaap Cost Of Services
CostOfServices
730612000 USD
CY2017Q3 us-gaap Costs And Expenses
CostsAndExpenses
350300000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1064500000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1064533000 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
377447000 USD
CY2018Q3 us-gaap Costs And Expenses
CostsAndExpenses
377400000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1109500000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1109479000 USD
CY2017Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
90700000 USD
CY2018Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
59800000 USD
CY2018Q2 us-gaap Debt Issuance Costs Line Of Credit Arrangements Gross
DebtIssuanceCostsLineOfCreditArrangementsGross
2400000 USD
CY2017Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1900000 USD
CY2018Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3700000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
17228000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14916000 USD
CY2017Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
56064000 USD
CY2018Q3 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
41149000 USD
CY2017Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4185000 USD
CY2017Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4200000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
13100000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
13139000 USD
CY2018Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3200000 USD
CY2018Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3164000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9882000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
9900000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
13139000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
9882000 USD
CY2017Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.02
CY2018Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.78
CY2017Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.00
CY2018Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.71
CY2017Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
89936000 USD
CY2018Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
92385000 USD
CY2017Q4 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
26400000 USD
CY2018Q3 us-gaap Equity Method Investment Aggregate Cost
EquityMethodInvestmentAggregateCost
31900000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4656000 USD
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
4373000 USD
CY2017Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
30610000 USD
CY2018Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
32443000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
22000 USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-738000 USD
CY2017Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
118800000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
358600000 USD
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
124500000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
369000000 USD
CY2017Q4 us-gaap Goodwill
Goodwill
319949000 USD
CY2018Q3 us-gaap Goodwill
Goodwill
324145000 USD
CY2017Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
373704000 USD
CY2017Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
373700000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
1113311000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
1113300000 USD
CY2018Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
417300000 USD
CY2018Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
417335000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
1228200000 USD
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
1228200000 USD
CY2017Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24025000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
51713000 USD
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
41373000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
122393000 USD
CY2017Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
900000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3149000 USD
CY2018Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1625000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
6461000 USD
CY2017Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9364000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17324000 USD
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9825000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
29984000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
315000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
11017000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-5430000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-670000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10846000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6166000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
22584000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
14758000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
201000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2462000 USD
CY2017Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
77130000 USD
CY2017Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
813482000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
12202000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-726000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5896000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
32000 USD
CY2017Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
271000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
279000 shares
CY2018Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
561000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
464000 shares
CY2017Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
46061000 USD
CY2018Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
44309000 USD
CY2017Q3 us-gaap Interest Expense
InterestExpense
1335000 USD
us-gaap Interest Expense
InterestExpense
3600000 USD
CY2018Q3 us-gaap Interest Expense
InterestExpense
1991000 USD
us-gaap Interest Expense
InterestExpense
5834000 USD
us-gaap Interest Paid
InterestPaid
2188000 USD
us-gaap Interest Paid
InterestPaid
2989000 USD
CY2017Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
44000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
104000 USD
CY2018Q3 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
29000 USD
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
263000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
226532000 USD
CY2018Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
79367000 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
232213000 USD
CY2017Q4 us-gaap Liabilities
Liabilities
297056000 USD
CY2018Q3 us-gaap Liabilities
Liabilities
280396000 USD
CY2018Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
725892000 USD
CY2017Q4 us-gaap Liabilities Current
LiabilitiesCurrent
215062000 USD
CY2018Q3 us-gaap Liabilities Current
LiabilitiesCurrent
219290000 USD
CY2018Q2 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
550000000 USD
CY2017Q4 us-gaap Long Term Debt
LongTermDebt
88800000 USD
CY2018Q3 us-gaap Long Term Debt
LongTermDebt
56100000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
78203000 USD
CY2018Q3 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
54853000 USD
CY2017Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
10638000 USD
CY2018Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
1209000 USD
CY2017Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
10600000 USD
CY2018Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1200000 USD
CY2017Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
78200000 USD
CY2018Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
54900000 USD
CY2017Q4 us-gaap Minority Interest
MinorityInterest
1105000 USD
CY2018Q3 us-gaap Minority Interest
MinorityInterest
1353000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4727000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-219182000 USD
CY2017Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
652000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2935000 USD
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1485000 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3672000 USD
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 Segments
CY2018Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
34 state
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23400000 USD
CY2017Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
23373000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
48800000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
48778000 USD
CY2017Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3558000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
11788000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-32898000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-12621000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
73542000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
159450000 USD
CY2017Q3 us-gaap Net Income Loss
NetIncomeLoss
14558000 USD
us-gaap Net Income Loss
NetIncomeLoss
34149000 USD
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
31377000 USD
us-gaap Net Income Loss
NetIncomeLoss
91885000 USD
CY2017Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
103000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
240000 USD
CY2018Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
171000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
524000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
39900000 USD
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
39888000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
118700000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
118721000 USD
CY2017Q4 us-gaap Other Assets Current
OtherAssetsCurrent
16268000 USD
CY2018Q3 us-gaap Other Assets Current
OtherAssetsCurrent
11949000 USD
CY2017Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49130000 USD
CY2018Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
53406000 USD
CY2017Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
38189000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
120223000 USD
CY2018Q3 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
40335000 USD
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
124119000 USD
CY2017Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3791000 USD
CY2018Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6253000 USD
CY2017Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1043000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3282000 USD
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1822000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2782000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
181402000 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
2433000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
6454000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
5421000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
24128000 USD
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
4074000 USD
CY2017Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
177900000 USD
CY2018Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
123600000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
436000 USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
3477000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9074000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5684000 USD
us-gaap Pension Expense
PensionExpense
6547000 USD
us-gaap Pension Expense
PensionExpense
6934000 USD
CY2017Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2017Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2018Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2017Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2018Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2017Q4 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2018Q3 us-gaap Preferred Stock Value Outstanding
PreferredStockValueOutstanding
0 USD
CY2017Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7329000 USD
CY2018Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
11679000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
118000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
51000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
622000 USD
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
563000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
127500000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4214000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2749000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1798000 USD
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
1787000 USD
CY2017Q3 us-gaap Profit Loss
ProfitLoss
14661000 USD
us-gaap Profit Loss
ProfitLoss
34389000 USD
CY2018Q3 us-gaap Profit Loss
ProfitLoss
31548000 USD
us-gaap Profit Loss
ProfitLoss
92409000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31122000 USD
CY2017Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
31100000 USD
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30200000 USD
CY2018Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30215000 USD
CY2017Q3 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
4069000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
91071000 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0 USD
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
70000000 USD
CY2017Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
204000 USD
CY2018Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
92089000 USD
CY2018Q3 us-gaap Share Based Compensation
ShareBasedCompensation
4842000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
12653000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
515321000 USD
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
444143000 USD
CY2017Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
516426000 USD
CY2018Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
445496000 USD
CY2017Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1782367 shares
CY2018Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
4269371 shares
CY2017Q4 us-gaap Treasury Stock Value
TreasuryStockValue
53713000 USD
CY2018Q3 us-gaap Treasury Stock Value
TreasuryStockValue
240536000 USD
CY2017Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34363000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34255000 shares
CY2018Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32691000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
33852000 shares
CY2017Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33838000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33640000 shares
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31815000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33075000 shares
us-gaap Comparability Of Prior Year Financial Data
ComparabilityOfPriorYearFinancialData
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications and Comparability</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain reclassifications have been made to prior periods&#8217; financial statements in order to conform to the current period&#8217;s presentation.</font></div></div>
us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:24px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our accounting and reporting policies conform with U.S. GAAP. In preparing the unaudited condensed consolidated financial statements, we are required to make estimates and assumptions that impact the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name View Source Status
0000896262-18-000010-index-headers.html Edgar Link pending
0000896262-18-000010-index.html Edgar Link pending
0000896262-18-000010.txt Edgar Link pending
0000896262-18-000010-xbrl.zip Edgar Link pending
amed-20180930.xml Edgar Link completed
amed-20180930.xsd Edgar Link pending
amed-20180930_cal.xml Edgar Link unprocessable
amed-20180930_def.xml Edgar Link unprocessable
amed-20180930_lab.xml Edgar Link unprocessable
amed-20180930_pre.xml Edgar Link unprocessable
amed-20183009x10xq.htm Edgar Link pending
amed-20183009xexx101.htm Edgar Link pending
amed-20183009xexx102.htm Edgar Link pending
amed-20183009xexx21.htm Edgar Link pending
amed-20183009xexx311.htm Edgar Link pending
amed-20183009xexx312.htm Edgar Link pending
amed-20183009xexx321.htm Edgar Link pending
amed-20183009xexx322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending